Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5873 | 1494 | 29.3 | 61% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
56 | 28576 | CHOLESTERYL ESTER TRANSFER PROTEIN//JOURNAL OF LIPID RESEARCH//HIGH DENSITY LIPOPROTEIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FRIEDEWALD FORMULA | Author keyword | 31 | 74% | 2% | 23 |
2 | NON HDL CHOLESTEROL | Author keyword | 21 | 43% | 3% | 38 |
3 | MIKE ROSENBLOOM CARDIOVASC | Address | 19 | 37% | 3% | 41 |
4 | BETA QUANTIFICATION | Author keyword | 15 | 88% | 0% | 7 |
5 | NON HDL C | Author keyword | 13 | 50% | 1% | 19 |
6 | NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL | Author keyword | 11 | 40% | 1% | 21 |
7 | APOB APOA I RATIO | Author keyword | 8 | 70% | 0% | 7 |
8 | FRIEDEWALD EQUATION | Author keyword | 8 | 60% | 1% | 9 |
9 | LIPID REFERENCE | Address | 7 | 64% | 0% | 7 |
10 | FRIEDEWALDS FORMULA | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FRIEDEWALD FORMULA | 31 | 74% | 2% | 23 | Search FRIEDEWALD+FORMULA | Search FRIEDEWALD+FORMULA |
2 | NON HDL CHOLESTEROL | 21 | 43% | 3% | 38 | Search NON+HDL+CHOLESTEROL | Search NON+HDL+CHOLESTEROL |
3 | BETA QUANTIFICATION | 15 | 88% | 0% | 7 | Search BETA+QUANTIFICATION | Search BETA+QUANTIFICATION |
4 | NON HDL C | 13 | 50% | 1% | 19 | Search NON+HDL+C | Search NON+HDL+C |
5 | NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL | 11 | 40% | 1% | 21 | Search NON+HIGH+DENSITY+LIPOPROTEIN+CHOLESTEROL | Search NON+HIGH+DENSITY+LIPOPROTEIN+CHOLESTEROL |
6 | APOB APOA I RATIO | 8 | 70% | 0% | 7 | Search APOB+APOA+I+RATIO | Search APOB+APOA+I+RATIO |
7 | FRIEDEWALD EQUATION | 8 | 60% | 1% | 9 | Search FRIEDEWALD+EQUATION | Search FRIEDEWALD+EQUATION |
8 | FRIEDEWALDS FORMULA | 6 | 100% | 0% | 4 | Search FRIEDEWALDS+FORMULA | Search FRIEDEWALDS+FORMULA |
9 | APOB | 5 | 14% | 2% | 36 | Search APOB | Search APOB |
10 | LDL P | 4 | 67% | 0% | 4 | Search LDL+P | Search LDL+P |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHEMISTRY STANDARDIZATION PROJECT | 59 | 62% | 4% | 61 |
2 | NON HDL CHOLESTEROL | 50 | 48% | 5% | 75 |
3 | INTERNATIONAL REFERENCE MATERIAL | 38 | 59% | 3% | 42 |
4 | FRIEDEWALD FORMULA | 28 | 69% | 2% | 24 |
5 | DEXTRAN SULFATE MG2 METHOD | 18 | 89% | 1% | 8 |
6 | HOMOGENEOUS ASSAYS | 17 | 68% | 1% | 15 |
7 | CANDIDATE REFERENCE | 12 | 86% | 0% | 6 |
8 | SWEDISH MALES | 11 | 65% | 1% | 11 |
9 | APOB APOA 1 RATIO | 11 | 78% | 0% | 7 |
10 | LIPID MEASURES | 9 | 55% | 1% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins A Meta-analysis | 2012 | 140 | 29 | 45% |
Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement | 2011 | 31 | 37 | 89% |
Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? | 2010 | 34 | 15 | 67% |
Methods for measurement of LDL-cholesterol: A critical assessment of direct measurement by homogeneous assays versus calculation | 2002 | 114 | 82 | 73% |
The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence | 2006 | 143 | 113 | 52% |
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel | 2006 | 222 | 88 | 35% |
Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula | 2003 | 53 | 22 | 86% |
Apolipoprotein Measurements: Is More Widespread Use Clinically Indicated? | 2009 | 33 | 33 | 61% |
Targets for LDL-lowering therapy | 2009 | 11 | 12 | 92% |
Apolipoprotein B and Apolipopotein A-I in Vascular Risk Prediction - A Review | 2014 | 1 | 38 | 74% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MIKE ROSENBLOOM CARDIOVASC | 19 | 37% | 2.7% | 41 |
2 | LIPID REFERENCE | 7 | 64% | 0.5% | 7 |
3 | CANC CONTROL HLTH PROMOT | 4 | 75% | 0.2% | 3 |
4 | CRMLN LIPID REFERENCE | 4 | 75% | 0.2% | 3 |
5 | CORE CLIN STUDIES | 3 | 42% | 0.3% | 5 |
6 | JULES THORNE | 2 | 67% | 0.1% | 2 |
7 | ENDCRINOL DIABET | 1 | 100% | 0.1% | 2 |
8 | KENANCO BIOSTAT | 1 | 100% | 0.1% | 2 |
9 | LIPOPROT DISORDERS | 1 | 50% | 0.1% | 2 |
10 | SECC QUIM CLIN | 1 | 50% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000198822 | GRADIENT GEL ELECTROPHORESIS//SMALL DENSE LDL//FAMILIAL COMBINED HYPERLIPIDEMIA |
2 | 0.0000149260 | REVUE DE L ALCOOLISME//CHOLESTEROL FRACTION//DILINOLEOYL PHOSPHATIDYLCHOLINE |
3 | 0.0000105474 | TG HDL C RATIO//TRIGLYCERIDE TO HDL CHOLESTEROL RATIO//DEOB |
4 | 0.0000093105 | HLTH BUR NANDAN CTY//BANTUS//DIETARY LIPID INTAKE |
5 | 0.0000090096 | APOLIPOPROTEINS A I AND B//FETAL CHOLESTEROL//TERM PERIOD |
6 | 0.0000089449 | CHYLOMICRON REMNANTS//POSTPRANDIAL LIPEMIA//CHYLOMICRON REMNANT |
7 | 0.0000085007 | TI TPYP REAGENT//GPO//GLYCEROL 3 PHOSPHATE OXIDASE |
8 | 0.0000082137 | STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN |
9 | 0.0000081791 | APOLIPOPROTEIN A I//REVERSE CHOLESTEROL TRANSPORT//APOLIPOPROTEIN A II |
10 | 0.0000081616 | FIBROUS PLAQUES//CHOLESTEROL SCREENING//PREVENT SECT |